Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neutropenia
Interventions: DRUG: AVI-014 versus Filgrastim
Sponsor: AviGenics